Viking Therapeutics notches success with weight-loss drug trial, …

Feb 27, 2024 · Viking Therapeutics said on Tuesday its experimental drug helped patients with obesity lose nearly 15% of their body weight on average in a mid-stage study, and its share …

CouponFollow Extension

15%
OFF

Viking Therapeutics Notches Success With Weight-loss Drug Trial, …

6 days from now

Feb 27, 2024 · Viking Therapeutics said on Tuesday its experimental drug helped patients with obesity lose nearly 15% of their body weight on average in a mid-stage study, and its share …

reuters.com

8%
OFF

Viking Oral Obesity Med Posts 6.8% Weight Loss For Highest Dose

6 days from now

Nov 4, 2024 · The biotech already began preparations for a phase 3 trial on the back of a midstage study’s readout that the highest, 15-mg, dose of the injectable was linked to mean …

fiercebiotech.com

2%
OFF

Viking Therapeutics' Weight-loss Pill Shows 'great Outcome' In Trial

6 days from now

Nov 4, 2024 · Oral GLP-1 drug in study led to average weight loss of 8.2% in a month at a 100 mg dose Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its …

morningstar.com

8%
OFF

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial ...

6 days from now

Nov 4, 2024 · The company's weight loss drug, which is being tested in oral and injectable forms, led to placebo-adjusted average weight loss of up to 6.8% of a patient's body weight in a …

investopedia.com

1%
OFF

Viking Therapeutics Obesity Drug's Data Raise Best-in-Class ...

6 days from now

Feb 27, 2024 · An experimental Viking Therapeutics obesity drug that hits the same targets as a commercialized Eli Lilly medication has clinical data showing it led to an average 13.1% weight …

medcitynews.com

2%
OFF

Viking Therapeutics Is More Than Just A Weight-loss Stock, And …

6 days from now

1 day ago · The company said obese adults taking the highest dose in a Phase 1 trial of 100 milligrams had an average weight loss of 8.2% from baseline over a four-week period.

morningstar.com

5%
OFF

Viking Stays In Obesity Drug Race With Early Data For Weight Loss Pill

6 days from now

Mar 26, 2024 · Dive Brief: A dual-acting weight loss pill from Viking Therapeutics helped people with obesity lose up to 5% of their body weight over four weeks in a small trial designed to …

biopharmadive.com

15%
OFF

Viking Therapeutics Notches Success With Weight-loss Drug Trial, …

6 days from now

Feb 27, 2024 · (Reuters) -Viking Therapeutics said on Tuesday its experimental drug helped patients with obesity lose nearly 15% of their body weight on average in a mid-stage study, …

yahoo.com

2%
OFF

Viking Therapeutics Is More Than Just A Weight-loss Stock, And

6 days from now

The company said obese adults taking the highest dose in a Phase 1 trial of 100 milligrams had an average weight loss of 8.2% from baseline over a four-week period. The 100 mg dose also …

msn.com

$300
OFF

Viking To Charge Quickly Into Phase 3 With Obesity Med

6 days from now

Jul 25, 2024 · Viking Therapeutics will launch a longship into phase 3 for the obesity drug VK2735 sooner than expected, with a clinical program expected to top $300 million.

fiercebiotech.com

15%
OFF

Viking Therapeutics Notches Success With Weight-loss Drug Trial, …

6 days from now

Feb 27, 2024 · Viking Therapeutics VKTX said on Tuesday its experimental drug helped patients with obesity lose nearly 15% of their body weight on average in a mid-stage study, and its …

tradingview.com

$125
OFF

Behind The $125 Billion GLP-1 Obesity Drug Boom: Four Key …

6 days from now

2 days ago · Roche’s pill-based weight-loss drug CT-388 that came out of its USD 2.7 billion acquisition of Carmot Therapeutics has seen promising results. Pfizer, after dropping two …

pharmaboardroom.com

FAQs about Viking Therapeutics notches success with weight-loss drug trial, … Coupon?

Does Viking Therapeutics (vktx) lose weight?

The oral version caused placebo-adjusted average weight loss of up to 6.8% in a recent trial, Viking said Monday. Viking Therapeutics (VKTX) shares fell Monday, handing back early gains, as analysts questioned the path ahead for its developmental weight-loss drugs even after news of upbeat results in clinical trials. ...

Does Viking's weight loss drug really help you lose weight?

The company's weight loss drug, which is being tested in oral and injectable forms, led to placebo-adjusted average weight loss of up to 6.8% of a patient's body weight in a recent trial of the oral version, Viking said Monday as part of an industry conference. ...

Does Viking Therapeutics help patients with obesity lose weight?

She has a postgraduate degree in International Journalism from City, University of London. Viking Therapeutics said on Tuesday its experimental drug helped patients with obesity lose nearly 15% of their body weight on average in a mid-stage study, and its share price rocketed, more than doubling in high volume. ...

Will Viking launch a new trial for weight-loss drug?

Lian said it “seems more than likely” that Viking will launch a further trial specifically to study the drug’s efficacy. Approval for Viking’s weight-loss drug is at least three years away, as the FDA will require at least two more trials, noted Evan Seigerman, an analyst at BMO Capital Markets. ...

Will Viking Therapeutics' obesity drug hold up in a Phase 3 clinical trial?

The weight loss achieved by Viking Therapeutics’ obesity drug tops results posted by Eli Lilly’s Zepbound in its pivotal test. But Viking still needs to show its results can hold up in a larger Phase 3 clinical trial. ...

Is Viking Therapeutics stock on a tear?

Viking Therapeutics stock (VKTX) has been on a tear this week after it announced the phase II clinical trial results for a new experimental drug in the booming weight-loss industry. On Tuesday, shares of Viking Therapeutics more than doubled, soaring over 120% to $85 as Wall Street cheered the results. ...